Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Arecor Therape (AREC) Share News

12345

IN BRIEF: Arecor wins patents in EU, China protecting insulin products

27th Jun 2023 11:28

Arecor Therapeutics PLC - West Sussex, England-based commercial biotechnology company - Arecor is awarded key patents in the EU and China protecting the novel formulations of its proprietary Arestat insulin products, AT278 and AT247. The European Patent Office awards patent EP3518892, while China National Intellectual Property Administration grants patent CN110582285. Firm's patent portfolio now comprises 36 patent families, with over 75 granted patents in Europe, the US and other key territories. Read More

TRADING UPDATES: Medica shareholders back takeover; Arecor optimistic

9th Jun 2023 14:34

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Friday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

2nd Jun 2023 15:43

Read More

TRADING UPDATES: Arecor launches Ogluo in Denmark and Sweden

15th May 2023 20:19

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

TRADING UPDATES: Narf Industries audit delay; Arecor wins patent

26th Apr 2023 14:32

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

IN BRIEF: Arecor Therapeutics annual loss widens amid higher costs

20th Apr 2023 14:42

Arecor Therapeutics PLC - West Sussex, England-based commercial biotechnology company - Posts total income of GBP3.5 million for 2022, up from GBP1.8 million in 2021. This includes revenue of GBP2.4 million, up from GBP1.2 million. Pretax loss widens to GBP10.5 million from GBP6.9 million. Research & Development costs increase to GBP8.6 million from GBP5.4 million a year earlier. Sales, General & Administrative costs also rise to GBP5.5 million from GBP2.9 million. Looking forward, 2023 will build on the solid platform produced in 2022 and will be "a year of accelerated delivery across the key areas of our business". Read More

Arecor Therapeutics hails patent protections from India and US

16th Feb 2023 13:29

(Alliance News) - Arecor Therapeutics PLC on Thursday celebrated several patent wins in the US and India, as it looks to strengthen its portfolio of pharmaceutical products. Read More

Arecor Therapeutics expands existing partnership with development deal

14th Feb 2023 09:18

(Alliance News) - Arecor Therapeutics PLC on Tuesday said that it has signed an additional formulation study agreement with its top five global pharmaceutical partner, building on a collaboration formed in 2022. Read More

TRADING UPDATES: Maintel earnings take hit; Arecor meets expectations

19th Jan 2023 21:55

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

Arecor transfers AT307 drug to Hikma for development, regains AT282

12th Jan 2023 17:55

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review. Read More

Arecor Therapeutics subsidiary launches Ogluo treatment in Austria

4th Jan 2023 08:18

(Alliance News) - Arecor Therapeutics PLC on Wednesday said its subsidiary Tetris Pharma Ltd has launched its Olguo treatment in Austria, the second European launch in its European roll-out strategy. Read More

TRADING UPDATES: Baillie revenue falls; Great Southern finds targets

22nd Nov 2022 22:01

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

TRADING UPDATES: AfriTin hails drilling finds; Severfield profit rises

22nd Nov 2022 20:02

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

TRADING UPDATES: De La Rue defends chair; Resolute Mining fundraise

11th Nov 2022 15:24

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

TRADING UPDATES: Alternative Income assets rise; Ironveld signs deal

2nd Nov 2022 16:20

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

TRADING UPDATES: AssetCo net assets fall; VH Global seals deal

11th Oct 2022 21:12

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Arecor Therapeutics interim loss widens as research costs up

8th Sep 2022 14:40

Arecor Therapeutics PLC - Essex, England-based biopharmaceutical company - Posts a widened pretax loss of GBP5.2 million in the six months to June 30, from GBP3.5 million a year earlier. Revenue, however, increases by 51% to GBP693,000 from GBP460,000, derived from "formulation development projects, in line with expectations". Research & Development costs soared to GBP4.8 million from GBP1.9 million a year earlier, Cash amounts to GBP13.7 million at June 30, compared to GBP22.1 million a year ago. Read More

UK earnings, trading statements calendar - next 7 days

1st Sep 2022 15:59

Read More

IN BRIEF: Arecor Therapeutics granted two patents by EU for biosimilar

9th Aug 2022 11:42

Arecor Therapeutics PLC - Essex, England-based biopharmaceutical company - Granted two patents by the European patent office protecting the company's formulations of adalimumab until 2038. Adalimumab is a biosimilar of AbbVie Inc's Humira which treats rheumatoid arthritis and Chohn's disease. Read More

IN BRIEF: Arecor raises funds to support Tetris Pharma acquisition

1st Aug 2022 15:29

Arecor Therapeutics PLC - Essex, England-based biopharmaceutical company - Agrees to acquire commercial stage pharmaceutical firm Tetris Pharma Ltd, which is expected to add a key commercial diabetes product to Arecor's portfolio. Read More

12345
FTSE 100 Latest
Value8,809.74
Change53.53